TOKYO, May 16, 2017 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, “Astellas”) today announced that it has completed the acquisition of Ogeda SA (formerly named Euroscreen SA, “Ogeda”), a drug discovery company located in Gosselies, Belgium, and…
May 17, 2017 at 05:25AM
from
No comments:
Post a Comment